CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464950. A total of 4 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $276,000 | -59.7% | 232,000 | -39.0% | 0.00% | 0.0% |
Q2 2022 | $685,000 | +59.7% | 380,600 | +79.0% | 0.00% | – |
Q1 2022 | $429,000 | -39.3% | 212,600 | -18.5% | 0.00% | -100.0% |
Q4 2021 | $707,000 | -39.3% | 260,900 | -0.0% | 0.00% | 0.0% |
Q3 2021 | $1,164,000 | -29.3% | 261,000 | -8.0% | 0.00% | -50.0% |
Q2 2021 | $1,646,000 | -75.4% | 283,800 | -70.2% | 0.00% | -80.0% |
Q1 2021 | $6,696,000 | +61.0% | 953,900 | +10.1% | 0.01% | +42.9% |
Q4 2020 | $4,160,000 | +136.4% | 866,700 | +187.1% | 0.01% | +16.7% |
Q3 2020 | $1,760,000 | -38.9% | 301,900 | -29.3% | 0.01% | -53.8% |
Q2 2020 | $2,881,000 | -9.6% | 426,800 | -14.8% | 0.01% | -50.0% |
Q1 2020 | $3,188,000 | -4.4% | 501,200 | +56.7% | 0.03% | +13.0% |
Q4 2019 | $3,335,000 | +97.6% | 319,900 | -25.5% | 0.02% | +64.3% |
Q3 2019 | $1,688,000 | +892.9% | 429,500 | +3667.5% | 0.01% | +600.0% |
Q2 2019 | $170,000 | -90.9% | 11,400 | -84.9% | 0.00% | -90.5% |
Q1 2019 | $1,876,000 | +27.9% | 75,600 | -7.5% | 0.02% | +61.5% |
Q4 2018 | $1,467,000 | +38.0% | 81,700 | +125.7% | 0.01% | +62.5% |
Q3 2018 | $1,063,000 | -59.0% | 36,200 | -36.5% | 0.01% | -63.6% |
Q2 2018 | $2,592,000 | -48.1% | 57,000 | -39.7% | 0.02% | -56.0% |
Q1 2018 | $4,990,000 | -51.0% | 94,500 | -36.9% | 0.05% | -30.6% |
Q4 2017 | $10,186,000 | -56.9% | 149,800 | -47.7% | 0.07% | -66.4% |
Q3 2017 | $23,608,000 | -11.5% | 286,500 | +0.6% | 0.21% | -22.7% |
Q2 2017 | $26,666,000 | +28.1% | 284,800 | -12.9% | 0.28% | +14.5% |
Q1 2017 | $20,820,000 | +577.3% | 327,000 | +372.5% | 0.24% | +706.7% |
Q4 2016 | $3,074,000 | +23.8% | 69,200 | +0.4% | 0.03% | +11.1% |
Q3 2016 | $2,484,000 | +722.5% | 68,900 | +213.2% | 0.03% | +575.0% |
Q2 2016 | $302,000 | -61.8% | 22,000 | -46.6% | 0.00% | -63.6% |
Q1 2016 | $791,000 | -79.1% | 41,200 | -62.0% | 0.01% | -75.6% |
Q4 2015 | $3,791,000 | -57.0% | 108,300 | +12.9% | 0.04% | -63.1% |
Q3 2015 | $8,819,000 | +243.7% | 95,900 | +228.4% | 0.12% | +238.9% |
Q2 2015 | $2,566,000 | +288.2% | 29,200 | +228.1% | 0.04% | +260.0% |
Q1 2015 | $661,000 | -34.0% | 8,900 | -50.3% | 0.01% | -33.3% |
Q4 2014 | $1,002,000 | -13.7% | 17,900 | -30.1% | 0.02% | -16.7% |
Q3 2014 | $1,161,000 | -33.1% | 25,600 | -38.9% | 0.02% | -33.3% |
Q2 2014 | $1,735,000 | +59.5% | 41,900 | +166.9% | 0.03% | +50.0% |
Q1 2014 | $1,088,000 | -65.2% | 15,700 | -69.7% | 0.02% | -61.7% |
Q4 2013 | $3,128,000 | +1017.1% | 51,900 | +1028.3% | 0.05% | +840.0% |
Q3 2013 | $280,000 | – | 4,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,500 | $18,558,000 | 6.18% |
GROUP ONE TRADING, L.P. | 8,900 | $661,000 | 0.01% |
SIMPLEX TRADING, LLC | 65 | $14,000 | 0.00% |
Citadel Advisors | 20,700 | $1,537,000 | 0.00% |